外骨格市場規模、成長と動向分析レポート 2026-2033年

世界の外骨格市場規模は、2025年には5億9002万米ドルと推定され、2033年には17億9000万米ドルに達するとGrand View Researchでは予測しています。
2026年から2033年にかけて年平均成長率（CAGR）14.48%で成長すると見込まれています。急速に増加する世界の高齢者人口、自動車、軍事、防衛、建設などのさまざまな産業における医療機器の採用率の上昇、脳卒中の発生率の上昇などが、外骨格市場の成長を牽引する主な要因となっています。

主要市場動向と洞察

• 北米の外骨格市場は、2025年に世界市場を牽引し、収益シェアは44.10%に達しました。
• 2025年には、北米で最大のシェアを占めたのは米国でした。
• 移動手段別に見ると、モバイルセグメントが2025年に62.64%で最大のシェアを占めました。
• 技術別に見ると、電動セグメントが2025年に最大のシェアを占めました。
• 装着部位別に見ると、下半身セグメントが2025年に最大のシェアを占めました。
• エンドユーザー別に見ると、ヘルスケアセグメントが2025年に最大のシェアを占めました。

さらに、脊髄損傷（SCI）の発生率の上昇は、世界市場における需要を押し上げると予想されます。例えば、米国国立脊髄損傷統計センター（NSCISC）によると、米国では毎年17,730件の新たなSCIが診断され、約291,000人がSCIを抱えて生活しています。

外骨格ソリューションは、従業員の健康をサポートし生産性を向上させるために業界全体で広く採用されており、より広範なウェアラブルロボット市場の中で重要なセグメントとして位置づけられています。需要の高まりにより、外骨格技術を専門とし、リハビリテーション向けのソリューションを提供するスタートアップが数多く出現しています。さらに、絶えず進化する外骨格業界は、市場参加者に予測期間中の採用を促進するための革新的な製品開発戦略を考案するよう促しています。2026年1月、RoboCTはCES 2026で軽量GoGo外骨格シリーズを発表し、同社が臨床リハビリテーションから消費者向けの日常的な移動ソリューションへと事業を拡大したことを示しています。2.3kgのAI搭載ウェアラブルは、歩行、着席、バランス補助などの活動に対してマルチモードのリアルタイム適応サポートを提供し、脳卒中後の回復、神経変性疾患、および日常的な移動ニーズを対象としています。

主な調査結果

• 技術統合：本研究は、外骨格の適応能力を高めるために、AI、ロボット工学、生体力学の統合を重視しています。これらの技術は、治療の個別化を可能にし、より個別化された効果的なリハビリテーションプロセスを実現します。
• 患者の移動性：軽量で装着しやすく、自然で直感的な動きを可能にする外骨格の開発において、大きな進歩が見られました。これにより、患者の快適性が向上し、リハビリテーションに不可欠な長時間の使用が促進されます。
• 市場への普及：技術の進歩にもかかわらず、本研究は、コスト、規制上の障壁、および医療監督の必要性が、リハビリテーションセンターにおける普及の妨げとなっていることを明らかにしています。
• 例：Ekso Bionics社のEksoGTは、脳卒中や脊髄損傷患者の歩行補助に使用される外骨格の代表的な例です。このデバイスは、患者の移動性とリハビリテーションの改善において良好な結果を示しています。

本レポートは、世界、地域、国レベルでの収益と販売量の成長を予測し、2021年から2033年までの各サブセグメントにおける業界動向の分析を提供します。この調査のために、Grand View Research, Inc.は、外骨格市場レポートを、可動性、技術、四肢、最終用途、地域に基づいてセグメント化しました。

Exoskeleton Market Summary

Furthermore, the growing incidence rate of spinal cord injuries (SCI) is expected to drive the demand across global markets. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., 17,730 new SCIs are diagnosed annually, and approximately 291,000 live with SCIs.

Exoskeleton solutions are widely adopted across industries to support employee health and boost productivity, positioning them as a critical segment within the broader wearable robot market. Growing demand has led to emergence of several startups expertizing in exoskeleton technology and providing solutions for rehabilitation. Furthermore, constantly evolving exoskeleton industry is driving market players to devise innovative product development strategies to boost adoption over the forecast period. In January 2026, RoboCT introduced its lightweight GoGo Exoskeleton series at CES 2026, marking the company’s expansion from clinical rehabilitation into consumer-focused daily mobility solutions. The 2.3 kg AI-powered wearable offers multi-mode, real-time adaptive support for activities such as walking, sitting, and balance assistance, targeting post-stroke recovery, neurodegenerative conditions, and everyday mobility needs.

Increasing prevalence of spinal cord injury is boosting the growth of the exoskeleton segment within the wearable robot market, as patients are increasingly recommended to use robotic wearable assistive devices to improve mobility and functional outcomes. RaThis has become major driver for adoption of exoskeleton by patients as well as healthcare providers. In September 2025, United Spinal Association reported that 250,000 to 390,000 people in the U.S. are living with spinal cord injury, with about 18,000 new cases each year, most often due to vehicle accidents and falls, and highlighted common secondary complications including depression, chronic pain, spasticity, pressure injuries, and bowel, bladder, and respiratory issues.

Some of the most common musculoskeletal injuries and disorders affecting the construction industry are occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). For instance, as per WHO data estimates published in July 2022, approximately 1.71 billion individuals across the globe have musculoskeletal disorders that include neck pain, lower back pain, fractures, amputation, rheumatoid arthritis, and osteoarthritis. Similarly, in 2022, according to the U.S. Bureau of Labor Statistics, approximately 502,380 workers have occupation-related musculoskeletal disorders across several industries. These are some of the driving factors boosting adoption of exoskeleton solutions owing to benefits associated with exoskeleton technology, such as augmenting or assisting users’ physical activity or capability, improving users’ health & productivity, and reducing fatigue experienced by industrial workers.

Rapid technological advancements in the exoskeleton segment of the wearable robot market are expected to boost demand for robotic assistive devices across healthcare and industrial applications. Increasing popularity and growing adoption of exoskeletons by companies are expected to contribute to market growth. In addition, increasing adoption of exoskeletons in manufacturing sector, logistics, automotive, and construction is leading to a rise in penetration of exoskeletons, thereby fueling the market growth. In May 2025, Wandercraft initiated clinical trials of its AI powered Personal Exoskeleton, using NVIDIA AI and simulation tools to enable individuals with spinal cord injuries, stroke, and severe mobility impairments to stand and walk with real time adaptive support.

The trend of including exoskeletons in health insurance coverage is rising, making them more accessible to patients. This is particularly evident in countries such as Germany, where specific exoskeleton systems are recognized for insurance procurement. For instance, in November 2023, ReWalk Robotics Ltd. appreciated the Centers for Medicare & Medicaid Services (CMS) for officially publishing the Calendar Year 2024 Home Health Prospective Payment System Rule. This regulation, which was issued on November 1, 2023, and is set to be implemented starting from January 1, 2024, confirms the classification of exoskeletons under the Medicare brace benefit category.

Case Studies & Insights

Case Study Title: “Exoskeletons for Medical Rehabilitation – A Review of Recent Advances”

Source: Journal of Assistive Technology, Tandfonline, 2023

Overview

This case study examines the advancements in medical exoskeletons, specifically for patients with spinal cord injuries, stroke recovery, and other neurological conditions. It highlights the key challenges and recent technological improvements in the development of exoskeletons that aim to restore mobility and improve rehabilitation outcomes.

Key Findings

• Technological Integration: The study emphasizes the integration of AI, robotics, and biomechanics to enhance the adaptive capabilities of exoskeletons. These technologies help to personalize therapy, allowing for a more tailored and effective rehabilitation process.
• Patient Mobility: Significant progress has been made in creating lightweight exoskeletons that are easier to wear and provide natural, intuitive movement. This improves patient comfort and encourages longer usage, which is vital for rehabilitation.
• Market Adoption: Despite technological advances, the study highlights that cost, regulatory hurdles, and the need for medical supervision limit wider adoption in rehabilitation centers.
• Example: Ekso Bionics’ EksoGT is a key example of an exoskeleton used for walking assistance in stroke and spinal injury patients. The device has shown positive results in improving patient mobility and rehabilitation.

Conclusion

• Exoskeletons are promising tools for rehabilitation, but cost-efficiency, user comfort, and long-term effectiveness need continued refinement for broader market integration

Market Concentration & Characteristics

The wearable robots/exoskeleton market is characterized by a high degree of innovation due to the rapid technological advancements driven by factors such as advancements in robotics and artificial intelligence technology. Novel and innovative applications of exoskeletons are constantly emerging, leading to the creation of new opportunities for market players. In May 2025, German Bionic unveiled Exia, an AI powered exoskeleton trained on real world motion data that delivers adaptive lift assistance of up to 38 kg and adjusts support in real time, targeting reduced musculoskeletal injury risk and improved productivity across industries such as manufacturing, logistics, retail, and healthcare.

The exoskeleton market is characterized by a high level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to access new robotic technologies needed to consolidate in a rapidly growing market and the increasing adoption of these newly developed exoskeletons. In January 2026, EKSO Bionics announced a proposed merger with Applied Digital that could result in the separation or sale of its exoskeleton business, including the Indego Personal system, amid continued financial pressure despite Medicare coverage and ongoing sales in the complex rehab technology market.

Well-developed regulatory framework and rising approval for the exoskeleton products from these regulatory bodies positively impact market growth. The certifications and standards provided by government authorities for exoskeletons in their manufacture, deployment, and use would enhance their adoption at workplace. In January 2026, Baltimore-based NextStep Robotics said it is seeking additional FDA authorization via a De Novo submission to expand use of its AMBLE lower-body exoskeleton beyond exercise therapy for stroke rehabilitation. The company cited NIH-funded clinical trial results showing sustained improvements in walking months after therapy, while advancing a subscription-based model to improve affordability for community clinics.

Traditional rehabilitation methods remain prevalent, and exoskeletons are emerging as valuable alternatives. They offer advantages such as enhanced mobility and independence for patients with spinal cord injuries or neurological disorders. The high cost and need for specialized training may limit their widespread adoption, positioning them as complementary rather than direct substitutes to conventional therapies.​

Several market players are expanding their business by entering new geographical regions to strengthen their market position and expand their product portfolio. Rising research and development activities create more opportunities for market players to enter new regions. In January 2026, NAVEE announced its geographical expansion from Europe to the U.S., unveiling its global intelligent mobility strategy at a Silicon Valley event. The company introduced five AI-enabled products, including Exo-Fit, a full-terrain wearable exoskeleton for human mobility, alongside solutions for land, air, and water travel.

Mobility Insights

The mobile segment led the market in 2025 with the largest revenue share of 62.64% and is anticipated to witness fastest CAGR over the forecast period. Factors such as a rise in research and development activities and a surge in demand for motor-equipped robots aiding human body mechanics are attributed to market growth. In January 2026, Sumbu unveiled its Exo-S3 consumer exoskeleton lineup at CES 2026, introducing AI powered, lightweight leg assistance designed for everyday mobility, injury prevention, and outdoor use. The Exo-S3 series uses dual-vector drive technology and human-intent recognition AI to adapt support across varied terrain, targeting reduced fatigue, improved movement efficiency, and broader consumer adoption of wearable mobility devices.

The fixed/stationary segment is expected to grow significantly, driven by increasing demand for rehabilitation and assisted living solutions. These devices, designed to aid patients with limited mobility, provide vital support for standing, posture correction, and walking stationary. Growth is further supported by rising adoption in hospitals and rehabilitation centers, where controlled environments favor tethered systems for repetitive therapy, clinical monitoring, and long-duration use. For instance, the NX A3-M is a fixed-frame exoskeleton designed for gait rehabilitation, offering improvements over the earlier NX-A3 model.

Technology Insights

The powered segment held the largest revenue share with 71.40% in 2025 owing to rising implementation of powered exoskeleton solutions in several industries to enhance personal safety and boost productivity. In addition, the rise in innovative product launches and benefits associated with powered technology products are smoother lifting motion, reduced strain on worker’s body, increased strength, force multiplier, and enhanced productivity. For instance, in August 2024, Arc’teryx and Skip teamed up to introduce the world’s first powered pants, a wearable exoskeleton designed to improve human mobility by providing powered support.

Non-powered technology segment is anticipated to register the fastest growth rate over the forecast period, driven by demand for cost-effective, lightweight solutions that assist with lifting and mobility without relying on external power sources. These devices use mechanical systems, such as elastics or springs, to enhance movement and reduce fatigue, making them ideal for industrial and rehabilitation applications. Key drivers include the rising need for manual labor assistance in logistics, construction, and healthcare sectors, where workers handle heavy loads. For instance, the UPLIFT exoskeleton utilizes elastic mechanisms to support lifting tasks, highlighting the growing adoption of affordable, non-powered solutions in the workforce.

Extremity Insights

By extremity, market is segmented into lower body,upper body and full body. Lower body segment dominated the market in terms of revenue share with 40.72% in 2025. owing to rising investments, growing incidence of lower body disabilities, and increasing adoption rates of exoskeleton products by geriatric populations and paralyzed patients for weight-bearing capabilities and mobility. Initiatives such as, in April 2024, the ABLE Exoskeleton, a lightweight and affordable hip-knee-powered device by ABLE Human Motion, has received CE Mark approval under the new Medical Device Regulation, enabling its commercial sale for spinal cord injury rehabilitation in the EU.

The upper body segment is anticipated to register the fastest growth rate over the forecast period due to benefits provided by exoskeleton products in the upper extremities, such as supporting disabled communities and rehabilitation aid in post-stroke, neurological, or musculoskeletal impairments. Furthermore, growing prevalence of neurological disorders led to a rise in market growth. For instance, in May 2022, according to data published by the European Academy of Neurology, globally, a neurological disease affects 1 in 3 people at some point in their life.

End Use Insights

Healthcare segment dominated the market in terms of revenue share with 48.76% in 2025, owing to the rising incidence rate of spinal cord injuries (SCIs), widespread adoption of these products & solutions in rehabilitation centers, and significant surge in treatment numbers are some of the key driving factors. Moreover, a growing number of regulatory approvals and rising awareness of technologically advanced systems are driving the demand & adoption rate of exoskeleton products in the healthcare industry. For instance, in October 2023, Wandercraft SAS launched in the U.S. commercial operations of its exoskeleton, Atalante X. The solution is used for individuals with mobility impairments.

Industry segment is anticipated to register the fastest growth over the forecast period owing to rising awareness levels towards the benefits of exoskeleton technologies in several industry applications and the rapidly growing incidence rate of occupation-related injuries. Furthermore, the surge in demand for novel technologies and growing adoption of the exoskeleton in multiple sectors such as construction, manufacturing, and distribution is expected to accelerate growth of the industry segment. In August 2024, Festool announced the U.S. launch of its ExoActive powered exoskeleton for construction tradespeople, an industrial wearable designed to reduce shoulder and arm strain during overhead and front-facing tasks by up to 30%, providing up to 11 pounds of arm support to improve productivity and reduce work-related injuries in construction and trade environments.

Key Exoskeleton Company Insights

Key players who focus on innovation, product development, and strategic partnerships to maintain their market positions dominate the exoskeleton market. For instance, in March 2023, Svaya Robotics developed quadruped robot and a wearable exoskeleton. The exoskeleton is specially designed to match the body structure of Indian soldiers, enhancing their physical strength to help them walk long distances without fatigue and carry heavy loads with reduced effort. The market share is concentrated among established players with extensive resources for research and development, while emerging players focus on cost-effective solutions and technological advancements.

Recent Developments

• In January 2026, Ascentiz unveiled a modular exoskeleton at CES 2026, featuring swappable hip and knee modules optimized with distinct drive technologies for natural movement assistance. The system integrates AI trained on over 690,000 gait cycles to deliver rapid mode switching and significant reductions in leg effort, knee cartilage pressure, and energy loss during dynamic and load-bearing activities.
• In January 2026, OYMotion Technology and Melexis formed a partnership to advance robot perception and control, combining OYMotion’s system integration with Melexis’s sensor technology. The collaboration targets commercialization of dexterous hands and rehabilitation exoskeletons, leveraging OYMotion’s EMG/EEG AI, lightweight designs, and global supply chain to grow in medical, industrial, and humanoid robotics.
• In February 2025, Chulalongkorn University has introduced the “Exoskeleton Wheelchair,” a robotic suit designed to assist people with disabilities in sitting, standing, and walking.

“I wanted to create a wheelchair that could walk. An ordinary wheelchair can only move on a regular path, but it cannot get on the bus or go up and down the stairs. So my view is that if a wheelchair could be folded up and help the person sitting in it to get up and walk, it would make it easier for people with reduced mobility to walk.”

– Assoc. Prof. Dr. Ronnapee Chaichawarat, a professor from the International School of Engineering (ISE), Chulalongkorn University

• In February 2025, Wandercraft launched a landmark clinical trial for the Personal Exoskeleton, the world’s first self-balancing device aimed at restoring natural standing, walking, bending, and reaching abilities for individuals with severe mobility impairments.

“The launch of this trial is a major milestone in our journey to redefine what mobility technology can achieve. We’ve seen the profound impact of our exoskeletons in rehabilitation centers, and now we are thrilled to explore how the Personal Exoskeleton could represent a significant leap forward in mobility and walking independence for people with severe walking impairment, starting with SCI, enabling them to walk hands-free without relying on crutches or walkers.”

– Matthieu Masselin, CEO of Wandercraft

• In January 2025, German Bionic unveiled the Apogee ULTRA, which offers 80 lbs (36 kg) of lifting support. It is designed to enhance worker safety and productivity in industries such as logistics, manufacturing, and healthcare.

“We know from extensive experience in both industrial and healthcare settings that there are moments in a worker’s day when tasks demand an extra level of strength – whether it’s lifting a particularly heavy package or mobilizing an incapacitated patient. That’s exactly why we created the Ultra-Mode, giving users that powerful boost they need to complete these challenging tasks more safely and with greater ease.”

– Norma Steller, Head of Development at German Bionic

• In December 2024, RoboCT’s UGO Series Rehab Exoskeleton received CE certification, officially recognizing it as a medical device.
• In November 2024, Hippos Exoskeleton will release a knee brace featuring airbags designed to help prevent ACL injuries.

“The core technology we invented is not only on the hardware side, but also on the software side: the AI, the data processing capability and the ability to use our AI model, which we designed by ourselves, to personalize the triggering threshold for every single individual, athletes, soldiers, patients.”

– Kylin Shaw, Hippos CEO

• In December 2022, Ekso Bionics announced the acquisition of Parker Hannifin Corporation’s Human Motion and Control business unit. This acquisition includes Parker’s Indego lower limb exoskeleton product line and the strategic development of robot-assisted prosthetic and orthotic devices.
• In June 2022, CYBERDYNE Inc. formed a business and capital alliance with LIFESCAPES Inc. This collaboration highlighted the combined effort to further leverage the exoskeleton technology arena and improve rehabilitation options for patients with severe paralysis.
• In June 2022, CYBERDYNE Inc. announced its collaboration with the Social Security Organization (SOCSO) in Malaysia. This initiative led to the expansion of Cybernics Treatment using hybrid assistive limb (HAL) for SOCSO-insured patients.

Exoskeleton Market Report Scope

Global Exoskeleton Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the exoskeleton market report on the basis of mobility, technology, extremity, end use and region:

• Mobility Outlook (Volume, 000′ Units, Revenue USD Million 2021 – 2033)
  • Mobile
  • Fixed/Stationary
• Technology Outlook (Volume, 000′ Units, Revenue USD Million 2021 – 2033)
  • Powered
    • Upper Body
    • Lower Body
    • Full Body
  • Non-powered
    • Upper Body
    • Lower Body
    • Full Body
• Extremity Outlook (Volume, 000′ Units, Revenue USD Million 2021 – 2033)
  • Upper Body
  • Lower Body
  • Full Body
• End Use Outlook (Volume, 000′ Units, Revenue USD Million 2021 – 2033)
  • Healthcare
  • Military
  • Industry
• Regional Outlook (Volume, 000′ Units, Revenue USD Million 2021 – 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Spain
    • Italy
    • France
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Mobility
1.2.2. Technology
1.2.3. Extremity
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Mobility outlook
2.2.2. Technology outlook
2.2.3. Extremity outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Exoskeleton Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of spinal cord injury
3.2.1.2. Increasing incidence of musculoskeletal disorders
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High procedural costs
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Exoskeleton Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
3.4. Key Trends in the Exoskeleton/Exo Robots Market
3.5. Key Developments in the Exoskeleton/Exo Robots Market
3.6. Patent Analysis
3.7. Patent Disputer
3.8. Case Studies & Insights
3.9. Supply Chain Analysis for Exoskeletons
3.10. Current Regulatory Analysis
3.11. Ecosystem Analysis
3.12. Pricing Analysis
3.13. Upcoming Innovations in the Market
Chapter 4. Exoskeleton Market Segment Analysis, By Mobility 2021 – 2033 (USD Million), Unit Volume (In Thousand)
4.1. Definition and Scope
4.2. Mobility Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Exoskeleton Market, By Mobility, 2021 – 2033
4.5. Exoskeleton Market Size & Forecasts, By Mobility, 2021 – 2033 (USD Million)
4.6. Exoskeleton Market Size & Forecasts, By Mobility, Unit Volume, 2021 – 2033 (In Thousand Units)
4.7. Mobile
4.7.1. Mobile market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
4.8. Fixed/Stationary
4.8.1. Fixed/stationary market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
Chapter 5. Exoskeleton Market Segment Analysis, By Technology 2021 – 2033 (USD Million), Unit Volume (In Thousand)
5.1. Definition and Scope
5.2. Technology Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Exoskeleton Market, By Technology, 2021 – 2033
5.5. Exoskeleton Market Size & Forecasts, By Technology, 2021 – 2033 (USD Million)
5.6. Exoskeleton Market Size & Forecasts, By Technology, Unit Volume, 2021 – 2033 (In Thousand Units)
5.7. Powered
5.7.1. Powered market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.7.2. Powered by Extremity
5.7.2.1. Upper body
5.7.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.7.2.2. Lower body
5.7.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.7.2.3. Full body
5.7.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.8. Non-Powered
5.8.1. Non-powered market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.8.2. Non-powered by Extremity
5.8.2.1. Upper body
5.8.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.8.2.2. Lower body
5.8.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
5.8.2.3. Full body
5.8.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
Chapter 6. Exoskeleton Market Segment Analysis, By Extremity 2021 – 2033 (USD Million), Unit Volume (In Thousand)
6.1. Definition and Scope
6.2. Extremity Market Share Analysis, 2025 & 2033
6.3. Segment Dashboard
6.4. Global Exoskeleton Market, By Extremity, 2021 – 2033
6.5. Exoskeleton Market Size & Forecasts, By Extremity, 2021 – 2033 (USD Million)
6.6. Exoskeleton Market Size & Forecasts, By Extremity, Unit Volume, 2021 – 2033 (In Thousand Units)
6.7. Upper Body
6.7.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
6.8. Lower Body
6.8.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
6.9. Full Body
6.9.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
Chapter 7. Exoskeleton Market: End Use Estimates & Trend Analysis
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2025 & 2033
7.3. Segment Dashboard
7.4. Global Exoskeleton Market, By End Use, 2021 – 2033
7.5. Exoskeleton Market Size & Forecasts, By End Use, 2021 – 2033 (USD Million)
7.6. Exoskeleton Market Size & Forecasts, By End Use, Unit Volume, 2021 – 2033 (In Thousand Units)
7.7. Healthcare
7.7.1. Healthcare market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
7.8. Military
7.8.1. Military market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
7.9. Industry
7.9.1. Industry market estimates and forecasts 2021 to 2033 (USD Million, 000’ Units)
Chapter 8. Exoskeleton Market: Regional Estimates & Trend Analysis by mobility, technology, extremity, and end use
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.4.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.6. Denmark
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.5.8. Norway
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.6.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.6.4. South Korea
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.6.5. Thailand
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.6.6. Australia
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.7.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.8.1.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4.5. Market volume estimates and forecasts 2021 to 2033 (000’ Units)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Exoskeleton/Exo Robots Key Market Performance Indicators
9.4. Company Profiles
9.4.1. Ekso Bionics
9.4.1.1. Overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. ARMASTEC PTE. LTD.
9.4.2.1. Overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Hocoma
9.4.3.1. Overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Lockheed Martin Corporation
9.4.4.1. Overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Suit X
9.4.5.1. Overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Rex Bionics Plc.
9.4.6.1. Overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. RB3D
9.4.7.1. Overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. ReWalk Robotics
9.4.8.1. Overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Cyberdyne, Inc.
9.4.9.1. Overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. ActiveLink (Panasonic Corporation)
9.4.10.1. Overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. DIH Medical
9.4.11.1. Overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 4 North America exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 5 North America exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 6 North America exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 7 North America exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 8 North America exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 9 North America exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 10 North America exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 11 U.S. exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 12 U.S. exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 13 U.S. exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 14 U.S. exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 15 U.S. exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 16 U.S. exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 17 U.S. exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 18 U.S. exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 19 Canada exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 20 Canada exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 21 Canada exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 22 Canada exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 23 Canada exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 24 Canada exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 25 Canada exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 26 Canada exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 27 Mexico exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 28 Mexico exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 29 Mexico exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 30 Mexico exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 31 Mexico exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 32 Mexico exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 33 Mexico exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 34 Mexico exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 35 Europe exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 36 Europe exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 37 Europe exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 38 Europe exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 39 Europe exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 40 Europe exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 41 Europe exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 42 Europe exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 43 Germany exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 44 Germany exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 45 Germany exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 46 Germany exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 47 Germany exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 48 Germany exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 49 Germany exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 50 Germany exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 51 U.K. exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 52 U.K. exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 53 U.K. exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 54 U.K. exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 55 U.K. exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 56 U.K. exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 57 U.K. exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 58 U.K. exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 59 Spain exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 60 Spain exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 61 Spain exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 62 Spain exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 63 Spain exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 64 Spain exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 65 Spain exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 66 Spain exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 67 Italy exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 68 Italy exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 69 Italy exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 70 Italy exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 71 Italy exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 72 Italy exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 73 Italy exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 74 Italy exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 75 France exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 76 France exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 77 France exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 78 France exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 79 France exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 80 France exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 81 France exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 82 France exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 83 Denmark exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 84 Denmark exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 85 Denmark exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 86 Denmark exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 87 Denmark exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 88 Denmark exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 89 Denmark exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 90 Denmark exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 91 Norway exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 92 Norway exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 93 Norway exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 94 Norway exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 95 Norway exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 96 Norway exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 97 Norway exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 98 Norway exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 99 Sweden exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 100 Rest of Europe exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 101 Rest of Europe exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 102 Rest of Europe exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 103 Asia Pacific exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 104 Asia Pacific exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 105 Asia Pacific exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 106 Asia Pacific exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 107 Asia Pacific exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 108 Asia Pacific exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 109 Asia Pacific exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 110 Asia Pacific exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 111 Japan exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 112 Japan exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 113 Japan exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 114 Japan exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 115 Japan exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 116 Japan exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 117 Japan exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 118 Japan exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 119 China exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 120 China exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 121 China exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 122 China exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 123 China exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 124 China exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 125 China exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 126 China exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 127 India exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 128 India exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 129 India exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 130 India exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 131 India exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 132 India exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 133 India exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 134 India exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 135 Australia exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 136 Australia exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 137 Australia exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 138 Australia exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 139 Australia exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 140 Australia exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 141 Australia exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 142 Australia exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 143 Thailand exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 144 Thailand exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 145 Thailand exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 146 Thailand exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 147 Thailand exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 148 Thailand exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 149 Thailand exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 150 Thailand exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 151 South Korea exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 152 South Korea exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 153 South Korea exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 154 South Korea exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 155 South Korea exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 156 South Korea exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 157 South Korea exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 158 South Korea exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 159 Rest of Asia Pacific exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 160 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 161 Rest of Asia Pacific exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 162 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 163 Rest of Asia Pacific exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 164 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 165 Rest of Asia Pacific exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 166 Rest of Asia Pacific exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 167 Latin America exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 168 Latin America exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 169 Latin America exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 170 Latin America exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 171 Latin America exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 172 Latin America exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 173 Latin America exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 174 Latin America exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 175 Brazil exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 176 Brazil exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 177 Brazil exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 178 Brazil exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 179 Brazil exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 180 Brazil exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 181 Brazil exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 182 Brazil exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 183 Argentina exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 184 Argentina exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 185 Argentina exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 186 Argentina exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 187 Argentina exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 188 Argentina exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 189 Argentina exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 190 Argentina exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 191 Middle East & Africa exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 192 Middle East & Africa exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 193 Middle East & Africa exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 194 Middle East & Africa exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 195 Middle East & Africa exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 196 Middle East & Africa exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 197 Middle East & Africa exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 198 Middle East & Africa exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 199 South Africa exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 200 South Africa exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 201 South Africa exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 202 South Africa exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 203 South Africa exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 204 South Africa exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 205 South Africa exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 206 South Africa exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 207 Saudi Arabia exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 208 Saudi Arabia exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 209 Saudi Arabia exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 210 Saudi Arabia exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 211 Saudi Arabia exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 212 Saudi Arabia exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 213 Saudi Arabia exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 214 Saudi Arabia exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 215 UAE exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 216 UAE exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 217 UAE exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 218 UAE exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 219 UAE exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 220 UAE exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 221 UAE exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 222 UAE exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)
Table 223 Kuwait exoskeleton market estimates and forecasts, by mobility, 2021 – 2033 (USD Million)
Table 224 Kuwait exoskeleton market volume estimates and forecasts, by mobility, 2021 – 2033 (Volume, 000’ Units)
Table 225 Kuwait exoskeleton market estimates and forecasts, by technology, 2021 – 2033 (USD Million)
Table 226 Kuwait exoskeleton market volume estimates and forecasts, by technology, 2021 – 2033 (Volume, 000’ Units)
Table 227 Kuwait exoskeleton market estimates and forecasts, by extremity, 2021 – 2033 (USD Million)
Table 228 Kuwait exoskeleton market volume estimates and forecasts, by extremity, 2021 – 2033 (Volume, 000’ Units)
Table 229 Kuwait exoskeleton market estimates and forecasts, by end use, 2021 – 2033 (USD Million)
Table 230 Kuwait exoskeleton market volume estimates and forecasts, by end use, 2021 – 2033 (Volume, 000’ Units)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Exoskeleton market: market outlook
Fig. 7 Exoskeleton competitive insights
Fig. 8 Parent market outlook
Fig. 9 Related/ancillary market outlook
Fig. 10 Exoskeleton market driver impact
Fig. 11 Exoskeleton market restraint impact
Fig. 12 Exoskeleton market: Mobility movement analysis
Fig. 13 Exoskeleton market: Mobility outlook and key takeaways
Fig. 14 Mobile market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 15 Fixed/stationary market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 16 Exoskeleton market: Technology movement analysis
Fig. 17 Exoskeleton market: Technology outlook and key takeaways
Fig. 18 Powered market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 19 Upper body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 20 Lower body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 21 Full body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 22 Non-powered market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 23 Upper body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 24 Lower body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 25 Full body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 26 Exoskeleton market: Extremity movement analysis
Fig. 27 Exoskeleton market: Extremity outlook and key takeaways
Fig. 28 Upper body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 29 Lower body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 30 Full body market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 31 Exoskeleton market: End Use movement analysis
Fig. 32 Exoskeleton market: End Use outlook and key takeaways
Fig. 33 Healthcare market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 34 Military market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 35 Industry market estimates and forecast, 2021 – 2033 (USD Million, 000’ Units)
Fig. 36 Global Exoskeleton market: Regional movement analysis
Fig. 37 Global Exoskeleton market: Regional outlook and key takeaways
Fig. 38 Global Exoskeleton market share and leading players
Fig. 39 North America, by country
Fig. 40 North America market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 41 North America market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 42 Key country dynamics
Fig. 43 U.S. market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 44 U.S. market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 45 Key country dynamics
Fig. 46 Canada market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 47 Canada market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 48 Key country dynamics
Fig. 49 Mexico market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 50 Mexico market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 51 Europe, by country
Fig. 52 Europe market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 53 Europe market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 54 Key country dynamics
Fig. 55 U.K. market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 56 U.K. market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 57 Key country dynamics
Fig. 58 Germany market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 59 Germany market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 60 Key country dynamics
Fig. 61 France market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 62 France market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 63 Key country dynamics
Fig. 64 Italy market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 65 Italy market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 66 Key country dynamics
Fig. 67 Spain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 68 Spain market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 69 Key country dynamics
Fig. 70 Denmark market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 71 Denmark market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 72 Key country dynamics
Fig. 73 Sweden market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 74 Sweden market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 75 Key country dynamics
Fig. 76 Norway market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 77 Norway market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 78 Asia Pacific, by country
Fig. 79 Asia Pacific market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 80 Asia Pacific market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 81 Key country dynamics
Fig. 82 China market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 83 China market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 84 Key country dynamics
Fig. 85 Japan market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 86 Japan market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 87 Key country dynamics
Fig. 88 India market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 89 India market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 90 Key country dynamics
Fig. 91 Thailand market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 92 Thailand market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 93 Key country dynamics
Fig. 94 South Korea market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 95 South Korea market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 96 Key country dynamics
Fig. 97 Australia market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 98 Australia market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 99 Latin America, by country
Fig. 100 Latin America market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 101 Latin America market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 102 Key country dynamics
Fig. 103 Brazil market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 104 Brazil market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 105 Key country dynamics
Fig. 106 Argentina market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 107 Argentina market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 108 Middle East and Africa, by country
Fig. 109 Middle East and Africa market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 110 Middle East and Africa market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 111 Key country dynamics
Fig. 112 South Africa market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 113 South Africa market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 114 Key country dynamics
Fig. 115 Saudi Arabia market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 116 Saudi Arabia market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 117 Key country dynamics
Fig. 118 UAE market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 119 UAE market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)
Fig. 120 Key country dynamics
Fig. 121 Kuwait market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 122 Kuwait market volume estimates and forecasts, 2021 – 2033 (Volume, 000’ Units)

---

---